6505--Metolazone Tablets (VA-26-00032237)

SOL #: 36E79726R0016Pre-Solicitation

Overview

Buyer

Veterans Affairs
Veterans Affairs, Department Of
NAC PHARMACEUTICALS (36E797)
HINES, IL, 60141, United States

Place of Performance

Place of performance not available

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

Drugs And Biologicals (6505)

Set Aside

No set aside specified

Timeline

1
Posted
Mar 31, 2026
2
Response Deadline
Apr 15, 2026, 7:30 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Department of Veterans Affairs (VA) National Acquisition Center intends to issue an unrestricted Request for Proposal (RFP), 36E79726R0016, for Metolazone Tablets. This procurement aims to secure an uninterrupted source of supply for the VA, Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). A single contract will be awarded to a responsible offeror. The solicitation is expected to be issued on or about April 1, 2026, with a tentative closing date of April 14, 2026.

Scope of Work

The awarded contractor will provide Metolazone Tablets in specific dosages and quantities:

  • 10mg Tablets: Estimated annual requirement of 700 bottles (100/BT).
  • 2.5mg Tablets: Estimated annual requirement of 7,649 bottles (100/BT).
  • 5mg Tablets: Estimated annual requirement of 6,614 bottles (100/BT). Offerors must specify the exact drug name as it appears on the label and provide a unique NDC number. Glass bottles are not acceptable.

Contract & Timeline

  • Type: Pre-solicitation for an Unrestricted Request for Proposal (RFP).
  • Duration: One base year plus four pre-priced one-year option periods.
  • Set-Aside: Unrestricted.
  • Solicitation Number: 36E79726R0016.
  • Solicitation Issue Date: On or about April 1, 2026.
  • Tentative Closing Date: April 14, 2026.
  • Response Date/Time: April 15, 2026, 2:30 PM Central Time.
  • Published Date: March 31, 2026.
  • Distribution: Contract items will be distributed through the VA's and DOD's respective Pharmaceutical Prime Vendor Programs.

Submission & Evaluation

The solicitation will be issued electronically in commercial item format, in accordance with FAR Part 12, via http://www.sam.gov. All responsible sources are encouraged to submit an offer. Offerors must continuously monitor the SAM.gov URL for any future amendments or miscellaneous documents, as no paper copies will be provided.

Additional Notes

  • NAICS Code: 325412 (Pharmaceutical Preparation Manufacturing).
  • Point of Contact: Amber Zavala (amber.zavala@va.gov).

People

Points of Contact

Amber.Zavala@va.govAmber ZavalaPRIMARY

Files

Files

Download

Versions

Version 1Viewing
Pre-Solicitation
Posted: Mar 31, 2026
6505--Metolazone Tablets (VA-26-00032237) | GovScope